Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Gastroenterology Research
|
January 13, 2025
Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint Inhibitors
Ashish Manne, Fode Tounkara, Eric Min, et al.
Blood
|
September 20, 2002
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration
Pierluigi Porcu, Charles F Eisenbeis, Ronald P Pelletier, et al.
Future Oncology (London, England)
|
June 26, 2020
Infigratinib in patients with advanced cholangiocarcinoma with <i>FGFR2</i> gene fusions/translocations: the PROOF 301 trial
Shalini Makawita, Ghassan K Abou-Alfa, Sameek Roychowdhury, et al.
Cancer Research
|
March 5, 2003
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma
Sameek Roychowdhury, Ruoqi Peng, Robert A Baiocchi, et al.
Oncotarget
|
February 6, 2019
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
Hui-Zi Chen, Russell Bonneville, Lianbo Yu, et al.
European Journal of Haematology
|
December 9, 2025
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Aseel Alsouqi, Ying Huang, Beth Christian, et al.
The Journal of Molecular Diagnostics : JMD
|
February 17, 2022
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling
Ian M Silverman, Meijuan Li, Karthikeyan Murugesan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study
Charles F Eisenbeis, Andrew Grainger, Beth Fischer, et al.
Prostate Cancer and Prostatic Diseases
|
May 3, 2019
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
Melanie A Krook, Hannah Barker, Hui-Zi Chen, et al.
The Oncologist
|
May 22, 2022
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
Karthikeyan Murugesan, Dexter X Jin, Leah A Comment, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Gastroenterology Research
|
January 13, 2025
Risk Factors Predicting Outcomes in Advanced Upper Gastrointestinal Cancers Treated With Immune Checkpoint Inhibitors
Ashish Manne, Fode Tounkara, Eric Min, et al.
Blood
|
September 20, 2002
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration
Pierluigi Porcu, Charles F Eisenbeis, Ronald P Pelletier, et al.
Future Oncology (London, England)
|
June 26, 2020
Infigratinib in patients with advanced cholangiocarcinoma with <i>FGFR2</i> gene fusions/translocations: the PROOF 301 trial
Shalini Makawita, Ghassan K Abou-Alfa, Sameek Roychowdhury, et al.
Cancer Research
|
March 5, 2003
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma
Sameek Roychowdhury, Ruoqi Peng, Robert A Baiocchi, et al.
Oncotarget
|
February 6, 2019
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
Hui-Zi Chen, Russell Bonneville, Lianbo Yu, et al.
European Journal of Haematology
|
December 9, 2025
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Aseel Alsouqi, Ying Huang, Beth Christian, et al.
The Journal of Molecular Diagnostics : JMD
|
February 17, 2022
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling
Ian M Silverman, Meijuan Li, Karthikeyan Murugesan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study
Charles F Eisenbeis, Andrew Grainger, Beth Fischer, et al.
Prostate Cancer and Prostatic Diseases
|
May 3, 2019
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
Melanie A Krook, Hannah Barker, Hui-Zi Chen, et al.
The Oncologist
|
May 22, 2022
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
Karthikeyan Murugesan, Dexter X Jin, Leah A Comment, et al.
Page
of 8